Journal article icon

Journal article

Genome-wide methylation profiling in Crohn's disease identifies altered epigenetic regulation of key host defense mechanisms including the Th17 pathway

Abstract:

Background Germline variation in the 71 Crohn's disease (CD) loci implicated by genome-wide association studies (GWAS) only accounts for approximately 25% of estimated heritability. The contribution of epigenetic alterations to disease pathogenesis is emerging as a research priority.

Materials and Methods: The methylation status of 27,578 CpG sites across the genome was analyzed using the Illumina Human Methylation27 assay in DNA extracted from whole blood samples from 40 adult females (21 ileal CD, 19 healthy controls) and 16 girls with childhood-onset CD, all nonsmokers. Our primary analysis compared methylation profiles in adult cases and controls.

Results Our data define a global methylation profile characteristic of ileal CD. In all, 1117 sites were differentially methylated (corrected P < 0.01); 50 showed significantly altered methylation in cases compared with controls (uncorrected P < 10−6, corrected P < 0.0006), including genes altering immune activation: MAPK13, FASLG, PRF1, S100A13, RIPK3, and IL-21R. Gene ontology analyses implicated immunity-related pathways as targets of epigenetic modification (immune system processes [P = 1.3 × 10−22], immune response [P = 8.1 × 10−16], defense responses to bacteria [P = 1.8 × 10−15]). Ingenuity canonical pathway analyses implicated dendritic cell activity (P = 2.4 × 10−8) and differential regulation of cytokines by interleukin (IL)-17A and IL-17F (P = 5.8 × 10−7). We identified a significant enrichment of methylation changes within 50 kb of CD GWAS loci (8.6-fold [P = 0.021] in adults; 2.4-fold [P = 0.009] in adults and children combined), including IL-27, IL-19, TNF, MST1, and NOD2. Methylation status was predictive of disease status (sensitivity 0.71, specificity 0.83). Disease activity, drug therapy, NOD2 and DNMT3A genotypes were not associated with methylation changes.

Conclusions These data provide an important insight into the impact of epigenetic mechanisms in the pathogenesis of CD.

Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1002/ibd.21912

Authors


More by this author
Role:
Author
ORCID:
0000-0001-8916-018X
More by this author
Role:
Author
ORCID:
0000-0003-4368-1961
More by this author
Role:
Author
ORCID:
0000-0003-3634-6428


More from this funder
Funder identifier:
https://ror.org/01613vh25
Grant:
CZB/4/540
More from this funder
Funder identifier:
https://ror.org/03x94j517
Grant:
G0600329
More from this funder
Funder identifier:
https://ror.org/058c0xb46
Grant:
M11-1


Publisher:
Oxford University Press
Journal:
Inflammatory Bowel Diseases More from this journal
Volume:
18
Issue:
5
Pages:
889-899
Publication date:
2011-10-21
Acceptance date:
2011-09-08
DOI:
EISSN:
1536-4844
ISSN:
1078-0998
Pmid:
22021194


Language:
English
Keywords:
Pubs id:
pubs:827886
UUID:
uuid:37545460-52e5-4d27-993e-73271d8d2962
Local pid:
pubs:827886
Source identifiers:
827886
Deposit date:
2018-08-09

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP